window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 14, 2025

  • News
  • About Us
Contact Us

clinical development

  • Biotech,Clinical Development,Drug Development,Events and Conferences,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Medicinova wins contract research and development innovation award at biotech breakthrough awards 2025

    MediciNova has been recognised with the Contract Research and Development [...]

    November 10, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Clinical studies,Market Access & Commercialization

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    November 13, 2025
  • Biotech,Clinical Trials,Diagnostics,Women in Pharma,Women's Health

    Beyond the gap: Nordic experts call for investment and collaboration to advance women’s health

    Women’s health remains underfunded, underdiagnosed and undervalued — but a [...]

    October 17, 2025
  • Biologics & Biosimilars,Clinical Development,Clinical Trials,Drug approval,Infectious Diseases,Pharmaceuticals and therapeutics,Regulatory Affairs,RNA Therapeutics

    Cidara Therapeutics receives FDA Breakthrough Therapy designation for CD388 in seasonal influenza prevention

    Cidara Therapeutics has received Breakthrough Therapy designation from the US [...]

    October 10, 2025
  • Central Nervous System,Clinical Trials,Drug Development,Pharmaceuticals and therapeutics

    Celon Pharma receives FDA clearance for Phase 3 trial of CPL’36 in schizophrenia

    Celon Pharma S.A. has received FDA clearance to advance its [...]

    October 8, 2025
  • Biotech,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics

    Veristat and AOBiome to discuss strategic CRO partnerships at Clinical Outsourcing Group 2025

    Veristat, a global clinical research organization (CRO) and consultancy, will [...]

    October 8, 2025
  • Central Nervous System,Clinical Development,Drug Development,Regulatory Affairs

    Alto Neuroscience receives FDA Fast Track designation for ALTO-101 to treat cognitive impairment in schizophrenia

    Alto Neuroscience has received FDA Fast Track designation for its [...]

    October 6, 2025
  • Cell & Gene Therapy,Clinical Development,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Vitalant launches national service hubs to expand patient access to cell and gene therapies

    Vitalant has launched a national hub-and-spoke model to expand patient [...]

    October 6, 2025
  • Biologics & Biosimilars,Biotech,Clinical Development,Partnerships & Funding

    NanoPhoria secures €83.5m Series A in largest-ever Italian biotech raise to advance heart failure therapy

    NanoPhoria Bioscience has completed an €83.5 million Series A financing [...]

    October 6, 2025
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    CTMC and Einstein Hospital Israelita launch global cell therapy alliance

    CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

    October 2, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top